These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nonesterified fatty acids in blood pressure control and cardiovascular complications. Egan BM; Greene EL; Goodfriend TL Curr Hypertens Rep; 2001 Apr; 3(2):107-16. PubMed ID: 11276390 [TBL] [Abstract][Full Text] [Related]
3. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster. Egan BM; Lu G; Greene EL Prostaglandins Leukot Essent Fatty Acids; 1999; 60(5-6):411-20. PubMed ID: 10471131 [TBL] [Abstract][Full Text] [Related]
4. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition. Leiter LA; Lewanczuk RZ Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626 [TBL] [Abstract][Full Text] [Related]
5. [Insulin resistance and renin-angiotensin-aldosterone system]. Saitoh S Nihon Rinsho; 2009 Apr; 67(4):729-34. PubMed ID: 19348235 [TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Cersosimo E; DeFronzo RA Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274 [TBL] [Abstract][Full Text] [Related]
12. Vascular signaling pathways in the metabolic syndrome. Rakugi H; Kamide K; Ogihara T Curr Hypertens Rep; 2002 Apr; 4(2):105-11. PubMed ID: 11884265 [TBL] [Abstract][Full Text] [Related]
13. Thiazolidinediones--tools for the research of metabolic syndrome X. Komers R; Vrána A Physiol Res; 1998; 47(4):215-25. PubMed ID: 9803467 [TBL] [Abstract][Full Text] [Related]
14. El papel de los ácidos grasos libres en la resistencia a la insulina. Vázquez-Jiménez JG; Roura-Guiberna A; Jiménez-Mena LR; Olivares-Reyes JA Gac Med Mex; 2017; 153(7):852-863. PubMed ID: 29414963 [TBL] [Abstract][Full Text] [Related]
16. Modulation of insulin resistance and hypertension by voluntary exercise training in the TG(mREN2)27 rat. Kinnick TR; Youngblood EB; O'Keefe MP; Saengsirisuwan V; Teachey MK; Henriksen EJ J Appl Physiol (1985); 2002 Aug; 93(2):805-12; discussion 797. PubMed ID: 12133896 [TBL] [Abstract][Full Text] [Related]
17. [Role of angiotensin in the metabolic syndrome and cardiovascular complications]. Rakugi H; Ogihara T Nihon Rinsho; 2002 Oct; 60(10):1898-903. PubMed ID: 12397681 [TBL] [Abstract][Full Text] [Related]
18. Direct renin inhibitor prevents and ameliorates insulin resistance, aortic endothelial dysfunction and vascular remodeling in fructose-fed hypertensive rats. Chou CL; Pang CY; Lee TJ; Fang TC Hypertens Res; 2013 Feb; 36(2):123-8. PubMed ID: 22895064 [TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin system and insulin resistance. Liu Z Curr Diab Rep; 2007 Feb; 7(1):34-42. PubMed ID: 17254516 [TBL] [Abstract][Full Text] [Related]
20. [The relationship between insulin resistance and endothelium-dependent vasodilatation in obese subjects]. Yu YR; Li HL; Yu HL; Wang C; Pu S Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1467-70. PubMed ID: 14521722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]